Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds-Reference-Cited by-同舟云学术

Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds

Published:2020-03-23 Issue:8 Volume:39 Page:2000028
ISSN:1868-1743
Container-title:Molecular Informatics
language:en
Short-container-title:Mol. Inf.

Author:

Ton Anh‐Tien¹,Gentile Francesco¹^ORCID,Hsing Michael¹,Ban Fuqiang¹,Cherkasov Artem¹

Affiliation:

1. Vancouver Prostate CentreUniversity of British Columbia 2660 Oak Street Vancouver, BC V6H 3Z6 Canada

Publisher

Wiley

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,Molecular Medicine,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/minf.202000028

Reference58 articles.

1. Coronaviruses — drug discovery and therapeutic options

2. SARS and MERS: recent insights into emerging coronaviruses

3. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

4. “Coronavirus latest: Chinese cases spike after changes to diagnosis method ” can be found under http://www.nature.com/articles/d41586-020-00154-w 2020.

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction mechanism of cold atmospheric plasmas and fusion peptides of spike protein in SARS-CoV-2 revealed by reactive molecular dynamics simulation;Physics of Plasmas;2024-09-01

2. New combined Inverse-QSAR and molecular docking method for scaffold-based drug discovery;Computers in Biology and Medicine;2024-09

3. Computational Simulation Study of Potential Inhibition of c‐Met Kinase Receptor by Phenoxy pyridine Derivatives: Based on QSAR, Molecular Docking, Molecular Dynamics;Chemistry & Biodiversity;2024-08-30

4. Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders;World Journal of Pediatrics;2024-08-28

5. Discovery of New Heteroaryldihydropyrimidine Compounds as HBV Capsid Protein Inhibitors Based on QSAR, Molecular Docking and Molecular Dynamics Simulations**;ChemistrySelect;2024-07-29